234 related articles for article (PubMed ID: 23676499)
1. Acylglycerol kinase augments JAK2/STAT3 signaling in esophageal squamous cells.
Chen X; Ying Z; Lin X; Lin H; Wu J; Li M; Song L
J Clin Invest; 2013 Jun; 123(6):2576-89. PubMed ID: 23676499
[TBL] [Abstract][Full Text] [Related]
2. Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2/STAT3 pathway.
Zhao C; Chen HY; Zhao F; Feng HJ; Su JP
Cytokine; 2021 Dec; 148():155595. PubMed ID: 34116927
[TBL] [Abstract][Full Text] [Related]
3. SOX12 contributes to the activation of the JAK2/STAT3 pathway and malignant transformation of esophageal squamous cell carcinoma.
Li C; Zhu M; Zhu J; Lu Q; Shi B; Sun B; Chen H
Oncol Rep; 2021 Jan; 45(1):129-138. PubMed ID: 33416144
[TBL] [Abstract][Full Text] [Related]
4. The role of AGK in thrombocytopoiesis and possible therapeutic strategies.
Jiang H; Yu Z; Ding N; Yang M; Zhang L; Fan X; Zhou Y; Zou Q; Hou J; Zheng J; Zhang L; Xu Y; Liu J
Blood; 2020 Jul; 136(1):119-129. PubMed ID: 32202634
[TBL] [Abstract][Full Text] [Related]
5. JAK2 inhibitor blocks the inflammation and growth of esophageal squamous cell carcinoma in vitro through the JAK/STAT3 pathway.
Fang J; Chu L; Li C; Chen Y; Hu F; Zhang X; Zhao H; Liu Z; Xu Q
Oncol Rep; 2015 Jan; 33(1):494-502. PubMed ID: 25405520
[TBL] [Abstract][Full Text] [Related]
6. On-target JAK2/STAT3 inhibition slows disease progression in orthotopic xenografts of human glioblastoma brain tumor stem cells.
Stechishin OD; Luchman HA; Ruan Y; Blough MD; Nguyen SA; Kelly JJ; Cairncross JG; Weiss S
Neuro Oncol; 2013 Feb; 15(2):198-207. PubMed ID: 23262510
[TBL] [Abstract][Full Text] [Related]
7. Targeting leucine-rich PPR motif-containing protein/LRPPRC by 5,7,4'-trimethoxyflavone suppresses esophageal squamous cell carcinoma progression.
Liu H; Zhou Y; Fredimoses M; Niu P; Ge Y; Wu R; Liu T; Li P; Shi Y; Shi Y; Liu K; Dong Z
Int J Biol Macromol; 2024 Jun; 269(Pt 1):131966. PubMed ID: 38697422
[TBL] [Abstract][Full Text] [Related]
8. B7-H4 facilitates proliferation of esophageal squamous cell carcinoma cells through promoting interleukin-6/signal transducer and activator of transcription 3 pathway activation.
Chen X; Wang L; Wang W; Zhao L; Shan B
Cancer Sci; 2016 Jul; 107(7):944-54. PubMed ID: 27088889
[TBL] [Abstract][Full Text] [Related]
9. Nimesulide inhibits the growth of human esophageal carcinoma cells by inactivating the JAK2/STAT3 pathway.
Liu JR; Wu WJ; Liu SX; Zuo LF; Wang Y; Yang JZ; Nan YM
Pathol Res Pract; 2015 Jun; 211(6):426-34. PubMed ID: 25724470
[TBL] [Abstract][Full Text] [Related]
10. TROP2 promotes the proliferation and metastasis of glioblastoma cells by activating the JAK2/STAT3 signaling pathway.
Hou J; Lv A; Deng Q; Zhang G; Hu X; Cui H
Oncol Rep; 2019 Feb; 41(2):753-764. PubMed ID: 30431125
[TBL] [Abstract][Full Text] [Related]
11. Induction of metastatic potential by TrkB via activation of IL6/JAK2/STAT3 and PI3K/AKT signaling in breast cancer.
Kim MS; Lee WS; Jeong J; Kim SJ; Jin W
Oncotarget; 2015 Nov; 6(37):40158-71. PubMed ID: 26515594
[TBL] [Abstract][Full Text] [Related]
12. Dehydrocostus Lactone Induces Apoptosis and Cell Cycle Arrest through Regulation of JAK2/STAT3/PLK1 Signaling Pathway in Human Esophageal Squamous Cell Carcinoma Cells.
Yang G; Sheng B; Li R; Xu Q; Zhang L; Lu Z
Anticancer Agents Med Chem; 2022; 22(9):1742-1752. PubMed ID: 34353270
[TBL] [Abstract][Full Text] [Related]
13. Carbon Ion Therapy Inhibits Esophageal Squamous Cell Carcinoma Metastasis by Upregulating STAT3 Through the JAK2/STAT3 Signaling Pathway.
Luo H; Yang Z; Zhang Q; Shao L; Wei S; Liu R; Li Z; Geng Y; Li C; Wang X
Front Public Health; 2020; 8():579705. PubMed ID: 33330321
[TBL] [Abstract][Full Text] [Related]
14. Autocrine Leukemia Inhibitory Factor Promotes Esophageal Squamous Cell Carcinoma Progression via Src Family Kinase-Dependent Yes-Associated Protein Activation.
Kawazoe T; Saeki H; Oki E; Oda Y; Maehara Y; Mori M; Taniguchi K
Mol Cancer Res; 2020 Dec; 18(12):1876-1888. PubMed ID: 33004621
[TBL] [Abstract][Full Text] [Related]
15. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
16. Reciprocal activation between PLK1 and Stat3 contributes to survival and proliferation of esophageal cancer cells.
Zhang Y; Du XL; Wang CJ; Lin DC; Ruan X; Feng YB; Huo YQ; Peng H; Cui JL; Zhang TT; Wang YQ; Zhang H; Zhan QM; Wang MR
Gastroenterology; 2012 Mar; 142(3):521-530.e3. PubMed ID: 22108192
[TBL] [Abstract][Full Text] [Related]
17. ATP binding to the pseudokinase domain of JAK2 is critical for pathogenic activation.
Hammarén HM; Ungureanu D; Grisouard J; Skoda RC; Hubbard SR; Silvennoinen O
Proc Natl Acad Sci U S A; 2015 Apr; 112(15):4642-7. PubMed ID: 25825724
[TBL] [Abstract][Full Text] [Related]
18. [Knockdown of Fez family zinc finger protein 1 antisense ribonucleic acid 1 (FEZF1-AS1) inhibits invasion and migration of esophageal squamous cell carcinoma cells by blocking JAK2/STAT3 pathway].
Cao Y; Wang X; Chen L
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2020 Apr; 36(4):317-324. PubMed ID: 32519669
[TBL] [Abstract][Full Text] [Related]
19. STAT5A-mediated SOCS2 expression regulates Jak2 and STAT3 activity following c-Src inhibition in head and neck squamous carcinoma.
Sen B; Peng S; Woods DM; Wistuba I; Bell D; El-Naggar AK; Lai SY; Johnson FM
Clin Cancer Res; 2012 Jan; 18(1):127-39. PubMed ID: 22090359
[TBL] [Abstract][Full Text] [Related]
20. Epiregulin reprograms cancer-associated fibroblasts and facilitates oral squamous cell carcinoma invasion via JAK2-STAT3 pathway.
Wang Y; Jing Y; Ding L; Zhang X; Song Y; Chen S; Zhao X; Huang X; Pu Y; Wang Z; Ni Y; Hu Q
J Exp Clin Cancer Res; 2019 Jun; 38(1):274. PubMed ID: 31234944
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]